Clinical Trial Update: A Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7249 Injection in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of HRS-7249 injection in healthy subjects, with hyperlipidemia listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• HRS-7249

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Hyperlipidemia | Phase 1 | Status: COMPLETED